Concepedia

Publication | Closed Access

P0886 : Efficacy and safety of grazoprevir/elbasvir +/- RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-edge treatment-experienced trial

38

Citations

0

References

2015

Year

No additional data available for this publication yet. Check back later!